POST Online Media Lite Edition


Rex Bionics appoints CEO

Staff writer |
Auckland, New Zealand - August 6, 2014, Auckland, New Zealand - Rex Bionics, a developer and manufacturer of hands-free robotic exoskeletons, announced the appointment of Crispin Simon as chief executive officer.

Article continues below

Mr. Simon, who has a 25-year track record in industry with significant success in a number of sub-sectors of healthcare including medical technology and medical devices, will formally join the Board of Rex Bionics as CEO in early October 2014.

Following a career which included working at NM Rothschild, McKinsey, Rexam and Smith & Nephew, where he was latterly President of the Endoscopy Division, Mr. Simon was Chief Executive of Biocompatibles International until its sale to BTG.

At Biocompatibles, he led a team that developed three medical products businesses: the Cardiovascular Stent business sold to Abbott Laboratories, the Contact Lens business sold to Cooper Industries, and the drug-eluting bead business which was sold as part of the disposal of the whole company to BTG.


Air New Zealand appoints Jeff McDowall as acting CEO
SkyCity Entertainment Group appoints new CEO
Rex Bionics CFO to retire in 2017
Spark New Zealand announces new CEO for Spark Ventures
Westland Milk Products appoints new CEO

What to read next

Ekso Bionics appoints Thomas Looby as president and CEO
Ekso Bionics appoints Ted Wang to board
Ekso Bionics adds Howard Palefsky to board